Insights

Market Opportunity Nivagen operates in the US generic prescription and OTC space with a large addressable market and a pipeline shaped by significant patent expirations over the next decade, presenting ongoing opportunities to supply cost-effective alternatives through global manufacturing partnerships.

Strategic Partnerships The company emphasizes a turnkey partnership model with FDA-qualified manufacturers and seeks co-development and in-licensing deals, offering potential partners access to accelerated US market entry and scalable production through its global alliances.

Recent M&A Activity Acquisition by PAI Pharma in 2026 and prior asset divestitures indicate a possible openness to strategic collaborations, asset or product line swaps, and optimization of the portfolio to focus on high-growth or high-margin generics and specialty products.

Innovative Manufacturing Nivagen and Persist AI collaboration to develop next-generation manufacturing processes for long-acting injectables signals interest in advanced formulations and differentiated products, creating sales opportunities for specialized LAI pipelines.

Financial Scale With revenue in the tens of millions and active fundraising/partnership history, there is potential for co-investment, licensing, and revenue-sharing deals with manufacturers or distributors seeking to scale US market penetration.

Nivagen Pharmaceuticals, Inc. Tech Stack

Nivagen Pharmaceuticals, Inc. uses 8 technology products and services including ICP-MS, Google Fonts API, Polyfill, and more. Explore Nivagen Pharmaceuticals, Inc.'s tech stack below.

  • ICP-MS
    Advanced Analytics And Data Science
  • Google Fonts API
    Font Scripts
  • Polyfill
    Javascript Libraries
  • Really Simple Discovery
    Miscellaneous
  • PHP
    Programming Languages
  • HTTP/3
    Web & Portal Technology
  • XTRA
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

Nivagen Pharmaceuticals, Inc.'s Email Address Formats

Nivagen Pharmaceuticals, Inc. uses at least 1 format(s):
Nivagen Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@nivagen.comJDoe@nivagen.com
100%

Frequently Asked Questions

What is Nivagen Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Nivagen Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nivagen Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s official website is nivagen.com and has social profiles on LinkedInCrunchbase.

What is Nivagen Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s SIC code is 8732 - Commercial Economic, Sociological, and Educational Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Nivagen Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Nivagen Pharmaceuticals, Inc. has approximately 139 employees across 2 continents, including North AmericaAsia. Key team members include Vice President - Projects And Manufacturing: V. M.General Manager - Quality: K. P.Manager - Business Development: P. P.. Explore Nivagen Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Nivagen Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Nivagen Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s tech stack includes ICP-MSGoogle Fonts APIPolyfillReally Simple DiscoveryPHPHTTP/3XTRAApache.

What is Nivagen Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@nivagen.com. Find more Nivagen Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Nivagen Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Nivagen Pharmaceuticals, Inc. has raised $31M in funding. The last funding round occurred on Aug 09, 2023 for $5M.

When was Nivagen Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc. was founded in 2009.
Nivagen Pharmaceuticals, Inc. logo

Nivagen Pharmaceuticals, Inc.

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Nivagen Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, acquisition, and sale of generic prescription drugs and over-the-counter products for the North American market. It aims to deliver high-quality products at affordable prices by leveraging global partnerships with FDA-approved manufacturing facilities around the world, focusing on a model that combines development, licensing, and sales services. The firm emphasizes a strategic partnership approach to reduce costs for consumers while creating value across the supply chain, and it actively seeks collaborations with contract research and manufacturing organizations to co-develop products, as well as opportunities to acquire existing ones.
Headquartered in Sacramento, California, the company operates within the pharmaceutical manufacturing industry and positions itself as a specialty provider that can offer turnkey solutions to small FDA-qualified manufacturers seeking entry into the U.S. market. Nivagen’s activities include developing and co-developing products, acquiring licenses, and delivering sales and marketing services, with a stated focus on leveraging global alliances to expand its product portfolio. A recent development noted in industry coverage is the acquisition of Nivagen Pharmaceuticals, Inc. by PAI Pharma, supported by Olympus Partners, reflecting ongoing consolidation in the sector.

Section iconCompany Overview

Phone number
SIC Code
8732 - Commercial Economic, Sociological, and Educational Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $31M

    Nivagen Pharmaceuticals, Inc. has raised a total of $31M of funding over 3 rounds. Their latest funding round was raised on Aug 09, 2023 in the amount of $5Mas a series_unknown.

  • $50M$100M

    Nivagen Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $31M

    Nivagen Pharmaceuticals, Inc. has raised a total of $31M of funding over 3 rounds. Their latest funding round was raised on Aug 09, 2023 in the amount of $5Mas a series_unknown.

  • $50M$100M

    Nivagen Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.